Complete AUA 2014 Coverage
Check out what your colleagues tweeted about during the AUA 2014 annual meeting in Orlando.
At its annual meeting, the American Urological Association provided details of its first guidelines for the medical management of urolithiasis.
Study compared surgeons who performed fewer than 100 robot-assisted radical prostatectomies with those who performed 100 or more.
Single-institution study finds most patients satisfied with the results and would have the surgery again.
Allowing 1, 2, or 3 or more days between the first and second injection of collagenase clostridium histolyticum does not impact efficacy.
This parameter can identify prostate cancer patients for whom adjuvant radiation therapy after radical prostatectomy may be of no benefit.
Detecting fluoroquinolone-resistant organisms may allow for targeted antibiotic prophylaxis and identification of men at risk for infection.
The risk of cancer-specific death at 1 year was 48% and 23% for patients whose disease recurred at 3 months and 3 years, respectively.
Patients should be selected carefully because of a higher incidence of locally advanced disease and regional lymph node metastases.
Researchers compared transurethral resection of the prostate with prostate artery embolization in a randomized trial.
PSA bounce was associated with significantly higher scores on the International Index of Erectile Function-15 questionnaire.
Study reveals a late recurrence rate of 3% and 5% at 15 and 20 years, respectively, after radiotherapy.
Perceived outcomes of patients aged 29 years or younger are different from those of patients in other age groups, study finds.
In a study, 84% of men treated with radical surgery or radiation had erectile dysfunction after a median 11 years after their PCa diagnosis.
Study reveals no significant impact on changes in penile curvature or length.
The proportion of patients undergoing the procedure has stayed at 6%-7% annually.
Larger tumor size, male sex, and higher nephrometry score indicate a greater likelihood that a renal mass is malignant, researchers report.
Their risk of death is 40% lower than that of patients who are not obese, study shows.
IIEF scores at 6 months post-op not significantly different from baseline, study finds.
A significant proportion of these men have vascular abnormalities, a study found.
Enzalutamide decreases the risk of radiographic progression and death compared with placebo in men not previously treated with docetaxel.
Intrauterine insemination success rates decrease by 20% with each 10-year increment in men's age.
Patients are less likely to have Gleason upgrading and extracapsular extension.
Ejaculatory function worsens, however, in men taking 5 alpha-reductase inhibitors.
Researchers observe a short-term significant decline erectile function at 1 month, but this fully recovers by 6 months.
Loss of penile sensation after plaque incision and grafting surgery for Peyonie's disease declines over time.
It has lower pathologic upgrade rates at radical prostatectomy compared with standard 12-core biopsy.
In a study of rats, penile traction had the edge for correcting curvature, but a vacuum erectile device was better for preserving erectile function.
The cure rate was 82.5% at 13 years after surgery, investigators report.
Synergistic effect observed in a study of 3,031 patients who underwent radical prostatectomy.
Even multiple treatments have a negligible effect, Canadian researchers concluded.
Renal and Urology News Articles
- CROWNWeb Reporting Gets Up to Speed With Implementation of Dashboard
- Prostate Cancer Gene Testing Guidelines Issued
- Radical Nephrectomy Linked With Worse Kidney Function, Survival
- Acute Kidney Injury Increases Risk for Hypoglycemia in Diabetes Pts
- USPSTF Questions Nontraditional CVD Risk Factors for Assessment
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)